Patents by Inventor Tibor T. GLANT

Tibor T. GLANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220218806
    Abstract: The invention relates to peptide heteroconjugates useful in treating Rheumatoid Arthritis (RA). The peptide heteroconjugates include a portion of the Human aggrecan protein conjugated to an Immune Cell Binding Ligand (ICBL) by a direct bond or divalent linker. The peptide heteroconjugates including combinations thereof, can be used as a vaccination for RA when combined with an adjuvant and administered to a subject.
    Type: Application
    Filed: May 11, 2019
    Publication date: July 14, 2022
    Applicant: CRL-SCI Corporation
    Inventors: Daniel H. Zimmerman, Tibor T Glant, Katalin MIKECZ, Roy E Carambula
  • Publication number: 20210128600
    Abstract: Described herein is a method for treating an autoimmune disease in a patient including administering to the patient in need thereof, a pharmaceutically effective amount of an epigenetic enzyme inhibitor.
    Type: Application
    Filed: April 26, 2019
    Publication date: May 6, 2021
    Applicant: Rush University Medical Center
    Inventors: Tibor A. RAUCH, Daniel M. TOTH, Tibor T. GLANT
  • Publication number: 20200338088
    Abstract: Methods of treating neutrophilic dermatoses and PTPN6 deficiencies in a subject are provided. The methods include administering a therapeutically effective amount of a pharmaceutical composition comprising spleen tyrosine kinase (SYK) inhibitor to the subject.
    Type: Application
    Filed: January 4, 2019
    Publication date: October 29, 2020
    Applicant: Rush University Medical Center
    Inventors: Andrei B. NESTEROVITCH, Tibor T. GLANT, Michael D. THARP